Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor
A CVS pharmacy

Life Health > Health Insurance

At CVS, Special ACA Health Enrollees Have High Claims

X
Your article was successfully shared with the contacts you provided.

What You Need to Know

  • Enrollment period rules are designed to help health insurers manage claim risk.
  • When COVID-19 hit, regulators temporarily changed the rules to keep more people covered.
  • CVS expects that those joining through special enrollment periods will be expensive to insure,

Insurers now have more evidence that people who sign up for Affordable Care Act exchange plans during the regular open enrollment period are healthier than people who sign up during special enrollment periods.

Tom Cowhey, the interim chief financial officer at CVS Health, recently talked about the high cost of covering special enrollment period enrollees at the company’s Aetna health insurance business, during a conference call with securities analysts.

CVS Health attracted more special enrollment period enrollees than it expected during the third quarter.

“These members, particularly when added late in the year, will drive a higher MBR,” Cowhey said.

Aetna’s MBR, or medical benefit ratio, is its ratio of health insurance claims to health insurance premiums.

What it means: The relatively high cost of covering ACA special enrollment period enrollees will push up the cost of coverage for any clients with individual exchange plans in 2024.

What insurers learn from the ACA exchange plan special enrollment periods could also serve as a case study that will make many financial services providers, including life insurers and annuity issuers, more reluctant to loosen any purchasing period or enrollment period rules that they developed to better manage risk.

The history: In 2013, in most states, health insurers could use medical underwriting when they sold individual health insurance. That meant that they could reject applicants with health problems like cancer or diabetes, and they could charge enrollees with health problems higher rates.

Starting in 2014, the Affordable Care Act eliminated traditional underwriting in the individual major medical market. Health insurers cannot reject applicants because of health problems, and the only factors they can consider when pricing coverage are the applicant’s age, location and tobacco use.

Health insurers feared that consumers would see a lack of medical underwriting as a reason to go without health coverage when they were healthy and pay premiums only when they thought they would have big hospital bills.

To prevent that, regulators, ACA public exchange programs and insurers developed an “open enrollment period” system, or limits on when people can buy health coverage without showing that they have what the government classifies as a good reason to be shopping for coverage.

This year, the ACA open enrollment period will last from Nov. 1 through Jan. 15 in most of the country.

Special enrollment periods: To buy coverage outside of the open enrollment period, consumers must qualify for a special enrollment period, or SEP.

Under ACA rules, consumers may qualify for special enrollment periods if they’ve moved, lost group health coverage, married or meet other eligibility requirements.

In recent years, because of the COVID-19 pandemic, regulators have extended regular open enrollment period deadlines and added many extra emergency special enrollment period categories, including one for people who are losing Medicaid coverage due to changes in pandemic-period Medicaid eligibility rules.

One question has always been whether open enrollment period rules and special enrollment period rules have much effect on claims.

One theory is that SEP enrollees might have higher-than-normal claims, because only people who suspect they might have health problems will go to the trouble of signing up for coverage through a special enrollment period.

CVS: During the CVS conference call, Cowhey did not say how much higher typical claim costs are for SEP enrollees than for regular enrollees, but the effect is big enough that he mentioned it several times.

CVS is now telling investors that it expects its medical benefit ratio to be about 86% for all of 2023 At the beginning of the year, the company predicted its 2023 medical benefit ratio would range from 84.2% to 85.2%.

The increased MBR estimate is due partly to higher benefits costs for individual exchange enrollees and partly due to to higher benefits costs for Medicare Advantage enrollees, Cowhey said.

But CVS reported $2.3 billion in net income for the third quarter on $90 billion in revenue, and Cowhey noted that bringing in special enrollment period enrollees could help CVS in the long run.

“We’ve repriced our individual exchange members as we get into to move forward towards our target margins in 2024,” Cowhey said.

That means the SEP enrollees who keep their coverage could help earnings next year, he said.

Other insurers’ views:  Centene CEO Sarah London emphasized the value of the “sophomore effect” on enrollees who come in through special enrollment periods.

When Centene keeps a special enrollment period enrollee into the second year, “we’ll have moved through any sort of early utilization” of health care services, she said.

At Molina Healthcare, executives predicted that the departure of some players with very low prices from the individual health market should make the market more stable in 2024.

Mark Keim, Molina’s CFO, said the company added about 40,000 enrollees through special enrollment period applications in the third quarter, and that, at this point, those enrollees look good to Molina.

Photo: David Paul Morris/Bloomberg


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.